Can We Better Optimize Vancomycin Monotherapy?


TO THE EDITOR—We read with interest the retrospective analysis by Wargo et al in which they compared vancomycin monotherapy with vancomycin in combination with clindamycin for empiric treatment of acute bacterial skin and skin-structure infections (ABSSSIs) [1, 2]. ABSSSIs are common and frequently treated without culture data, rendering evaluations of… (More)
DOI: 10.1093/cid/civ1022


Cite this paper

@article{Mehta2016CanWB, title={Can We Better Optimize Vancomycin Monotherapy?}, author={Sapna Mehta and Hannah R Russo}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2016}, volume={62 6}, pages={811} }